Tema de Pesquisa

Supplements

Evidence-based supplements, vitamins, minerals, nootropics, and longevity interventions

217 artigos

NMN vs NR Supplements in 2026: What the Evidence Actually Shows
Supplements

NMN vs NR Supplements in 2026: What the Evidence Actually Shows

A rigorous product review reveals major quality gaps in NAD+ supplements and what dosing evidence actually supports.

Revisão
20 de abr. de 2026 0
NMN vs NR: Which NAD+ Booster Actually Delivers Results in 2026
Supplements

NMN vs NR: Which NAD+ Booster Actually Delivers Results in 2026

A head-to-head comparison of NMN and NR supplements reveals distinct benefit profiles — and major quality gaps across popular brands.

Revisão
20 de abr. de 2026 0
Four-Supplement Combo Extends Mouse Lifespan by 33% Starting in Old Age
Supplements

Four-Supplement Combo Extends Mouse Lifespan by 33% Starting in Old Age

A quercetin, NR, urolithin A, and alpha-lipoic acid combination boosted remaining lifespan in aged mice by 33%, even on a Western diet.

Comunicado de Imprensa
19 de abr. de 2026 0
Fisetin Targets Zombie Cells That Drive Aging and Strawberries Lead the Pack
Supplements

Fisetin Targets Zombie Cells That Drive Aging and Strawberries Lead the Pack

Fisetin is emerging as a top senolytic candidate, clearing senescent cells linked to aging — and strawberries are its richest dietary source.

Comunicado de Imprensa
19 de abr. de 2026 0
Metformin and Rapamycin May Blunt Exercise Adaptations, Study Suggests
Supplements

Metformin and Rapamycin May Blunt Exercise Adaptations, Study Suggests

Two popular longevity drugs show evidence of interfering with the body's response to exercise — a critical tradeoff for active users.

Comunicado de Imprensa
19 de abr. de 2026 0
FDA Panel to Revisit Compounded Peptide Access in July 2025
Supplements

FDA Panel to Revisit Compounded Peptide Access in July 2025

The FDA will convene advisory panels in July 2025 to reconsider whether compounding pharmacies can legally produce certain popular peptides removed from approved lists in 2023.

Comunicado de Imprensa
17 de abr. de 2026 0
Bryan Johnson Warns About Peptide Risks Before You Start Taking Them
Supplements

Bryan Johnson Warns About Peptide Risks Before You Start Taking Them

Longevity expert Bryan Johnson shares critical safety considerations and potential risks you need to know before using peptides.

Vídeo
14 de abr. de 2026 0
Ligandrol SARM Reduces Endurance and Disrupts Hormones in Male Rats
Supplements

Ligandrol SARM Reduces Endurance and Disrupts Hormones in Male Rats

New study reveals popular bodybuilding supplement ligandrol impairs cardiovascular fitness and hormonal health despite muscle strength gains.

Artigo Científico
12 de abr. de 2026 0
NAD Supplements May Not Boost Muscle Function as Expected, New Study Suggests
Supplements

NAD Supplements May Not Boost Muscle Function as Expected, New Study Suggests

Research challenges popular belief that NAD supplements improve muscle performance, finding minimal functional impact when NAD levels drop.

Artigo Científico
10 de abr. de 2026 0
New Test Detects Nine Performance-Enhancing Muscle Growth Inhibitors in Athletes
Supplements

New Test Detects Nine Performance-Enhancing Muscle Growth Inhibitors in Athletes

Scientists develop comprehensive screening method for banned muscle-building drugs that block natural growth limiters.

Artigo Científico
5 de abr. de 2026 0
Creatine Boosts Strength and Power But Benefits Vary by Age and Sex
Supplements

Creatine Boosts Strength and Power But Benefits Vary by Age and Sex

Meta-analysis of 69 studies reveals creatine's differential effects on upper/lower body strength across populations.

Artigo Científico
5 de abr. de 2026 0
PQQ Supplement Boosts Mitochondria But Fails to Affect Weight or Metabolism in Mice
Supplements

PQQ Supplement Boosts Mitochondria But Fails to Affect Weight or Metabolism in Mice

Three-month study shows PQQ increases mitochondrial biogenesis and antioxidant capacity but has no impact on body weight or energy expenditure.

Artigo Científico
5 de abr. de 2026 0
AnteriorPágina 4 de 19Próximo